IBSA Pharma recalls TIROSINT levothyroxine oral solution (112 mcg/mL) with subpotent drug risk. Affected lots manufactured in 2023-2024 may cause inadequate thyroid hormone levels.
Subpotent Drug
IBSA Pharma has recalled TIROSINT levothyroxine oral solution because it may contain less active drug than labeled. This could lead to inadequate thyroid hormone levels in patients taking the medication.
The product contains less active levothyroxine than labeled, which may result in insufficient thyroid hormone levels. This could cause symptoms like fatigue, weight gain, or depression in patients.
People prescribed levothyroxine medication by a doctor who received this specific product. Those with thyroid conditions are most at risk of inadequate hormone levels.
Check the product label for 'TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL'. Look for lot numbers 220414 (exp. 10/2023), 220852 (exp. 02/2024), or 220970 (exp. 03/2024).
Look for lot numbers 220414, 220852, or 220970 on the packaging.
The product may contain less active drug than labeled, so it is not recommended for use. Patients should contact their doctor for alternative medication.
Check the product label for lot numbers 220414 (exp. 10/2023), 220852 (exp. 02/2024), or 220970 (exp. 03/2024).
Contact your doctor to discuss alternative medication options. Do not use the product if you have thyroid hormone levels that are too low.
We’ve drafted a message you can send IBSA Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0342-2023 — IBSA Pharma IBSA Pharma Hello, I own a IBSA Pharma that is covered by recall D-0342-2023 from IBSA Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
